HOME News & Features Top 10 Sites Cancer Centers Ask An Expert
Search
  My Community News Letter Contact Us Get Involved Site Index
• AIDS Related
• Bladder Cancer
• Brain Tumor
• Breast Cancer
• Carcinoid Tumors
• Cervical Cancer
• Colorectal Cancer
• Endometrial Cancer
• Esophageal Cancer
• Head and Neck
• Kidney Cancer
• Leukemia
• Liver Cancer
• Lung Cancer
• Lymphoma
• Melanoma
• Multiple Myeloma
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
• Skin Cancer
• Sarcoma
• Stomach Cancer
• Testicular Cancer
• Thyroid Cancer
• Pediatric Cancers
• Surgery
• Chemotherapy
• Radiotherapy
• BM Transplant
• Immune Rx
• Alternative Rx
• Diet / Nutrition
• Side Effects
Types of Cancer >  Bladder Cancer >  In the Spotlight
Bladder Cancer Outcomes Best Predicted by Tumor Marker Combinations
Finding altered expression of four key cell cycle regulators, especially when these are viewed in combination, may make it possible for physicians to predict the clinical outcome for transitional cell carcinoma of the bladder following a cystectomy, according to the results of a recent study.

The key cell cycle regulators are p53, p21, pRB and p16, all tumor suppressor genes.

The findings of the study, the first to analyze the four markers in combination in order to get a better picture of bladder cancer prognosis, were published in the March 15 issue of The Journal of Clinical Oncology.

The altered expression of p53 was the strongest sign of cancer progression, followed by the altered expression of p21, thus suggesting that the p53/p21 combination may have a stronger relation with outcome measures than the pRB/p16 combination.

The study also found that the more marker accumulations there are, the more adverse the impact of bladder cancer on progression and mortality.

The study involved the staining of archival tumor specimens for the four cell cycle regulators from 80 individuals with bladder cancer who had undergone a radical cystectomy, or removal of the bladder. The aim of the study was to see if the expression of these regulators is linked with the stage, progression and prognosis of bladder cancer. The patients involved were observed for a median of 101 months.

The study showed that altered expression in the four cell cycle regulators was found in many of the tumors. The investigators noted the independent association of each marker alteration with prognosis, progression and survival following a cystectomy.

Altered expression of p53 was found in 56%, of p21 in 49%, of pRB in 54% and of p16 in 53% of the tumors compared with those found in normal bladder epithelium.

Altered expression was also found in at least one of the tumor suppressor genes in 83% of bladder cancer tumors, with 26% of the tumors having alterations in three of these genes.

A comprehensive six-year study is currently underway to validate these retrospective observations.

Resource: The Cancer Information Network
Reviewer: J. Jay Lu, M.D.
Publish Date: May 15, 2004

Know What to Ask Your Doctor
Learn about a treatment option that works in a different way than traditional therapies.
Related Articles
Overview
What Questions Patients Should Ask About Bladder Cancer
Known Risk Factors of Bladder Cancer
Reducing Risks of Bladder Cancer
Surgical Treatment for Bladder Cancer: Reconstructive Surgery
Pre-Operative Chemotherapy And Radical Surgery Should Be Used For Patients With Locally Advanced Bla
• Cancer Patients' Bill of Rights
• Should Cancer Patients Get a Second Opinion?
• What is Cancer Staging?
• How You Can Help Your Doctor
• Metastatic Cancer: Questions and Answers
• NCI Booklet: Dealing With Bone Metastasis
• Advanced Cancer: Living Each Day
• What You Need To Know About Cancer
• The Biopsy Report: A Patient's Guide
• Clinical Trials: What Cancer Patients Need to Know
• Make a Difference in Your Cancer Treatment with Good Nutrition
_
Home | About Us | Contact Us | Disclaimer | Privacy Policy
© The Cancer.net